Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Psychopharmacology|September 15, 2018
Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress modelKai Zhang, Hidetoh Toki, Yuko Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1Kosuke Kanuma, Katsunori Omodera, Mariko Nishiguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2016
TASP0434299: A Novel Pyridopyrimidin-4-One Derivative as a Radioligand for Vasopressin V1B ReceptorKazumi Koga, Mitsukane Yoshinaga, Yoshikatsu Uematsu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2025
Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonistHirohiko Hikichi, Yuichi Tokumaru, Atsuki Taruta, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 7, 2012
Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitorToshiyuki Kawasaki, Toshiyuki Marumo, Keiko Shirakami, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 31, 2020
A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in RodentsNoriko Hino, Toshiyuki Marumo, Makiko Kotani, et al.
Psychopharmacology|April 15, 2015
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophreniaShigeyuki Chaki, Toshiharu Shimazaki, Jun-Ichi Karasawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2005
Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonistsShigeyuki Chaki, Takeo Funakoshi, Shiho Hirota-Okuno, et al.
Behavioural Pharmacology|December 28, 2012
The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptideYukio Ago, Naoki Hiramatsu, Toshihiro Ishihama, et al.
Biological Psychiatry|June 28, 2018
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-NorketamineChun Yang, Shizuka Kobayashi, Kazuhito Nakao, et al.
Pageof 14